diethylumbelliferyl phosphate: inhibits the neutral cholesteryl ester hydrolase activity responsible for hydrolysis of cellular lipid droplet cholesteryl ester [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 16219277 |
| CHEMBL ID | 1719220 |
| SCHEMBL ID | 404341 |
| MeSH ID | M0222267 |
| Synonym |
|---|
| diethylumbelliferyl phosphate |
| NCGC00165788-01 |
| deup |
| SCHEMBL404341 |
| CHEMBL1719220 |
| diethyl (2-oxochromen-7-yl) phosphate |
| diethyl(2-oxo-2h-chromen-7-yl)phosphate |
| diethyl (2-oxo-2h-chromen-7-yl) phosphate |
| PD193172 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 3.5481 | 0.2512 | 15.8432 | 39.8107 | AID504327 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||